Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
- Lead Co-Inventor and Licensor of RNADD’s Molecular Diagnostics Platform to Help Guide its Commercialization - - Company’s President Expands Role - BALTIMORE, April 04, 2022 (GLOBE NEWSWIRE) --...
-
- License Enables Development of RNADD’s AntiSense Molecular Diagnostic Platform for Home-Use Infectious Disease Testing - BALTIMORE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics,...
-
BALTIMORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform to democratize point-of-care and home-use...
-
BALTIMORE, July 08, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
-
BALTIMORE, June 03, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
-
BALTIMORE, June 01, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
-
BALTIMORE, May 11, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
-
BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD) announced today the publication of a stepwise protocol for an RNA-extraction-free nano-amplified colorimetric test...